PIK3CA and neoplasm: No significant association with overall survival was seen when assessing PIK3CA mutations in the primary (log-rank p = 0.27; Fig. 3a) or relapse tumor (log-rank p = 0.089; Fig. 3b), or if present in either the primary or relapse tumor (log-rank p = 0.37; Fig. 3c).